Drugmaker Cited for GMP, Quality Issues

Drug Industry Daily
A A
A PET finished dose manufacturer in Ohio was cited by the FDA after investigators witnessed numerous cGMP violations and potential quality problems on a January site visit.

To View This Article:

Login

Subscribe To Drug Industry Daily